Abstract：Objective To study the clinical value of combined measurement of fractional exhaled nitric oxide (FeNO) and nasal fractional exhaled nitric oxide (FnNO) and its correlation with the level of asthma control. Methods A total of 120 children who were diagnosed with asthma from January to June, 2018 and were in the chronic persistent stage were enrolled as subjects. The childhood asthma control test (C-ACT) was performed for all the 120 children. According to the C-ACT score, these children were divided into 4 groups:complete control group with a C-ACT score of > 23, partial control group with a C-ACT score of 20-23, and uncontrolled group with a C-ACT score of ≤ 19 (n=40 each). According to the presence or absence of allergic rhinitis, they were divided into 2 groups:non-rhinitis group with 55 children and rhinitis group with 65 children. A total of 40 children who underwent physical examination during the same period of time were enrolled as the control group. FeNO and FnNO levels were measured for all the 120 children. Results The uncontrolled group had the highest level of FeNO, followed by the partial control group and the complete control group (P P P P Conclusions FeNO can be used to assess the level of asthma control in children, and its combination with FnNO may be useful for the evaluation of the degree of inflammation in the upper and lower airways and provide a basis for the combined treatment of the upper and lower airways.
MU Dong-Qin,PAN Jia-Hua. Correlation of fractional exhaled nitric oxide in the upper and lower airways with the level of asthma control [J]. CJCP, 2019, 21(5): 426-430.
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention[EB/OL]. (2016). https://ginasthma.org/wp-content/uploads/2016/04/wms-GINA-2016-main-report-final.pdf.
Horváth I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard:exhaled biomarkers in lung disease[J]. Eur Respir J, 2017, 49:1600965.
Hanson JR, De Lurgio SA, Williams DD, et al. Office-based exhaled nitric oxide measurement in children 4 years of age and older[J]. Ann Allergy Asthma Immunol, 2013, 111(5):358-363.
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5):602-615.
Jang WN, Park IS, Choi CH, et al. Relationships between exhaled nitric oxide and atopy profiles in children with asthma[J]. Allergy Asthma Immunol Res, 2013, 5(3):155-161.
[11]
Pavord ID, Beasley R, Agusti A, et al. After asthma:redefining airways diseases[J]. Lancet, 2018, 391(10118):350-400.
[12]
Lluncor M, Barranco P, Amaya ED, et al. Relationship between upper airway diseases, exhaled nitric oxide, and bronchial hyperresponsiveness to methacholine[J]. J Asthma, 2018. doi:10.1080/02770903.2018.1429465.[Epub ahead of print]
[13]
Visitsunthorn N, Mahawichit N, Maneechotesuwan K. Association between levels of fractional exhaled nitric oxide and asthma exacerbations in Thai children[J]. Respirology, 2017, 22(1):71-77.
[14]
Price D, Ryan D, Burden A, et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care[J]. Clin Transl Allergy, 2013, 3(1):37.
[15]
Palm JP, Alving K, Lundberg JO. Characterization of airway nitric oxide in allergic rhinitis:the effect of intranasal administration of L-NAME[J]. Allergy, 2015, 58(9):885-892.
[16]
Alsaadi MM, Habib SS, Al Muqhem BA, et al. Significance of fractional exhaled nitric oxide measurements in detecting primary ciliary dyskinesia in Saudi children[J]. Saudi Med J, 2013, 34(1):24-28.
[17]
Kambara R, Minami T, Akazawa H, et al. Lower airway inflammation in eosinophilic chronic rhinosinusitis as determined by exhaled nitric oxide[J]. Int Arch Allergy Immunol, 2017, 173(4):225-232.
[18]
Nakano H, Ide H, Imada M, et al. Reduced nasal nitric oxide in diffuse panbronchiolitis[J]. Am J Respir Crit Care Med, 2000, 162(6):2218-2220.
[19]
Oka A, Hirano T, Yamaji Y, et al. Determinants of incomplete asthma control in patients with allergic rhinitis and asthma[J]. J Allergy Clin Immunol Pract, 2017, 5(1):160-164.
[20]
Oka A, Matsunaga K, Kamei T, et al. Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation[J]. J Allergy Clin Immunol Pract, 2014, 2(2):172-178.
[21]
Agache I, Akdis CA. Endotypes of allergic diseases and asthma:an important step in building blocks for the future of precision medicine[J]. Allergol Int, 2016, 65(3):243-252.
[22]
Kou W, Li X, Yao H, et al. Meta-analysis of the comorbidity rate of allergic rhinitis and asthma in Chinese children[J]. Int J Pediatr Otorhinolaryngol, 2018, 107:131-134.
[23]
Bousquet J, Schünemann HJ, Samolinski B, et al. Allergic Rhinitis and its Impact on Asthma (ARIA):achievements in 10 years and future needs[J]. J Allergy Clin Immunol, 2012, 130(5):1049-1062.
